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Abstract
Computer aided diagnosis (CAD) systems are important in obtaining precision medicine and patient driven solutions for various
diseases. One of the main brain tumor is the Glioblastoma multiforme (GBM) and histopathological tissue images can provide
unique insights into identifying and grading disease stages. In this study, we consider nuclei segmentation method, feature extrac-
tion and disease stage classiﬁcation for brain tumor histopathological images using automatic image analysis methods. In particular
we utilized automatic nuclei segmentation and labeling for histopathology image data obtained from The Cancer Genome Atlas
(TCGA) and check for signiﬁcance of feature descriptors using K-S test and classiﬁcation accuracy using support vector machine
(SVM) and Random Forests (RF). Our results indicate that we obtain classiﬁcation accuracy 98.6% and 99.8% in the case of
Object-Level features and 82.1% and 86.1% in the case of Spatial Arrangement features, respectively.
c© 2016 The Authors. Published by Elsevier B.V.
Peer-review under responsibility of KES International.
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1. Introduction
In the ﬁeld of histopathology, quantitative and eﬃcient analysis are paramount in devising precision medicine
and patient speciﬁc diagnosis. Therefore, over the years many studies on evaluation methods for histopathological
tissue images have been reported1. One of the malignant tumor is based on Glioma which occur in the brain and the
prognosis is usually quite worse. Disease stage classiﬁcation of Glioma is very important in the ﬁeld of histopathology.
However, there are various problems exists in doing manual disease stage classiﬁcation. First, the number of tissue
samples is enormous and this gives much burden to pathologists because they have to analysis them manually, and in
some case pathologists diagnose these images during surgery. Therefore, there is a demand for quickly analysis to do
that. In addition, the criteria of analysis heavily depend on each pathologists experience and perception. From this
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(a) LGG (b) HGG (c) Patch extraction and separation
Fig. 1. (a) Lower-Grade Glioma (LGG). (b) High-Grade Glioma (Glioblastoma multiforme) (GBM). (c) How to separate from big .svs format
image to patched images.
background, many studies on computational pathology using computer vision techniques have been reported1,2,3,4,5.
As discussed in1 computer-assisted diagnosis (CAD) systems to detect tumors from histopathological images require
strong feature extractions and further classiﬁcation analysis to forecast patients prognosis. It also showed that the
employed feature descriptors were eﬀective for cytopathology and histopathology. However, we note that most of
them were applied to only speciﬁc diseases like breast cancer, esophagitis and so on. Therefore, we cannot judge
whether these descriptors are ineﬀective for other tissue type images or not6.
This paper discusses the method of nuclei segmentation using custom designed image processing and analysis
steps, and describe the performance of various feature descriptors which are then used to evaluate disease stages of
Glioma and classify them. In this paper, the feature descriptors were applied to Glioma images obtained from The
Cancer Genome Atlas (TCGA), and we determined signiﬁcant descriptors for Glioma images. We also tested support
vector machine (SVM), and Random Forests (RF)7 classiﬁcation methods. We show that our image analysis pipeline
can be used eﬀectively in feature extraction and disease stage classiﬁcation for Glioma histopathological images.
Further our proposed pipeline is general in the sense that it is extensible to other tissue type images.
Rest of the paper is organized as follows. Section 2 and Section 3 illustrates the performance of our proposed
method with other segmentation schemes. Section 4 concludes the paper.
2. Disease stage classiﬁcation
In this study, we used human brain histopathological images of Glioma which were obtained from TCGA Data.
Generally, Glioma tissue images can be categorized into 4 grades based their disease stages. In particular, the status
of Grade 3 and 4 are so serious and have poor prognoses. Actually, TCGA Data has 2 types image of Glioma, and
these are Brain Lower-Grade Glioma (LGG) and Glioblastoma multiforme (GBM), and LGG is Grade 1 and 2, GBM
is Grade 3 and 4, respectively. We used these two distinct types image as the experimental materials. Figures 1 show
examples of materials of those image. In this image, nucleus were stained deep purple and other tissues were stained
pale purple, red and so on using H&E staining method. As you can see, features of the organization are diﬀerent
from each other. Generally, these diﬀerences come from disease progression, i.e. genes expressions. In the previous
research, we used an image each category, LGG and GBM. However we thought that stained state is diﬀerent from
each images, and this caused bad inﬂuence to accuracy of disease progression. Therefore, in this paper, we used 10
LGG images and 10 GBM images respectively to avoid this problem. Obtained images from TCGA Data are .svs
format. These are very big size, for example one of the image is about 30000x30000 pixels. Therefore it is unsuited
for processing. For that reason, we divided original images to patched images whose sizes were 2000x2000 pixels,
and then the patched images including suﬃcient nuclei were used as experimental materials. Figure 1 shows how to
dividing original image to patched images and the criteria as experimental material. In this paper, we used 10 .svs
format images in each category, and we obtained 100 patched images from a single .svs format image. Therefore, we
used 1000 patched images in each category.
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Fig. 2. Our proposed pipeline for the Glioma histopathology nuclei segmentation.
2.1. Nuclei Segmentation
In this study, we employed CellProﬁler8 to implement our nuclei segmentation pipeline. CellProﬁler is software
designed for histopathology image processing and supports basic methods and algorithms as libraries.
Figure 2 shows the pipeline (ﬂow of processing) of our segmentation method. The pipeline mainly consists of 3
steps:
(1) pre-processing (yellow steps),
(2) rough segmentation (green ones), and
(3) nuclei separation (blue ones).
In the cases of the input images, nuclei are stained deep purple and others are red (or light purple) by H&E staining
method, and nuclei can be observed as dark-colored objects compared with others. With consideration for such
features, the proposed method emphasized dark areas in the image. In this step, the input image was converted to a
gray-scale image by using Color To Gray module and then, Smooth module was applied to the converted image. In
this step, we set parameters of these modules to illuminate red colored objects, e.g. blood cells, in the image, because
we doesn’t need blood cells but cell nucleus. Figures 3 (a), (b) and (c) show the input image, the converted image and
applied image, respectively.
Next, nucleus in the image were roughly segmented by using the following procedure. In this step, we used
Enhance Or Suppress Features module to emphasize dark areas, i.e. nuclei, and then the inverted image like Figure 3
(d) was obtained. After this, Apply Threshold module was used to get the binary image shown in Figure 4 (e). As you
can see, nuclei regions could be roughly extracted from the obtained image, but there were nuclei-attached regions
that should be separated each other. Further fuzzy smoothing and thresholding techniques9,10 can be used to improve
these preliminary pre-processing steps.
To separate these regions, we prepared the inverted image without enhancement (Figure 3 (f)) by using Image Math
module and the smoothed image (Figure 3 (c)). Then, we obtained the rough segmentation image by superimposing
the binary image (Figures 3 (e)) and the inverted image (Figure 3 (f)). In this step, Mask Image module was employed.
Figure 3 (g) shows the result of rough segmentation by the above procedure.
As the last step, we separated nuclei attached regions into each nucleus based on pixel values. Generally, a nuclei
attached region has some peaks of pixel values like a multimodal distribution. In addition, the ideal distribution of
pixel values of a single nucleus is unimodal. Thus, we ﬁrst detected local minimum points of pixel values in the region
and then traced the points using Identify Primary Objects and Converts Object To Image modules. In these step, we
also removed nuclei overlapping with boundaries of the image, because such nuclei could not be extracted correctly
1205 Kiichi Fukuma et al. /  Procedia Computer Science  96 ( 2016 )  1202 – 1210 
(a) Input (b) Color to gray (c) Smoothing (d) Enhance or suppress
(e) (f) (g) (h)
Fig. 3. Example patch image and its corresponding steps of proposed pipeline for obtaining Glioma histopathology nuclei segmentation and
labelling process. (a) Input histopathology image, (b) color to gray conversion, (c) image smoothing, (d) enhancing or suppressing operation, (e)
automatic thresholding, (f) image math operations, (g) after masking, and (h) nuclei identiﬁcation and labeling.
(a) Voronoi Tessellation (b) Delaunay Triangulation (c) Minimum Spanning Tree
Fig. 4. Sample spatial-arrangement features extracted from example histopathology image given in Figure 3 (a).
and it harmed segmentation accuracy. Finally, segmentation result was obtained by coloring each nucleus (Figure 3
(h)).
2.2. Feature extraction
In the literature, feature descriptors can be categorized into
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Table 1. List of object-level feature descriptors for histopathological image analysis.
Type Features
Object-level Features —– # of Nuclei, Area
Elliptical Major Axis Length,
Minor Axis Length,
Eccentricity, Orientation,
Elliptical Deviation,
Extent, Aspect Ratio
Convex Hull Convex Area,
Convex Deﬁciency, Solidity
Bounding Box Extent, Aspect Ratio
Boundary Perimeter, Radii,
Perimeter Curvature
Other Shape Equivalent Diameter, Sphericity,
Compactness, Inertia Shape
Table 2. List of spatial-arrangement feature descriptors for histopathological image analysis.
Type Features
Spatial-arrangement Features Voronoi Tessellation # of Nodes, # of Edges,
Edge Length, Cyclomatic #,
# of k-Walks, Degree, Spectral Radius,
Randic Index, Voronoi Area,
Voronoi Area Disorder,
Perimeter, Roundness Factor,
Roundness Factor Homogeneity
Delaunay Triangulation # of Nodes, # of Edges,
Edge Length, Cyclomatic #,
# of Triangles, # of k-Walks,
Degree, Spectral Radius,
Randic Index
Minimum Spanning Tree # of Nodes, # of Edges,
Edge Length, Degree,
Spectral Radius, Randic Index
(1) Object-Level, and
(2) Spatial-Arrangement features.
Tables 1 and 2 show the extracted features list. Object-Level features are features related to sizes and shapes
of the nuclei. Spatial-Arrangement features describe topological features based on graph theory. We used Voronoi
Tessellation (VT), Delaunay Triangulation (DT) and Minimum Spanning Tree (MST)11. Samples of these graphs
were showed in Figure 4, respectively. To calculate them, we applied the features deﬁned in the literature to the
Glioma images, and their statistical signiﬁcances were evaluated by using Kolmogorov-Smirnov (K-S) test. In this
paper, the signiﬁcance level was set to 0.01.
2.3. Disease stage classiﬁcation
The signiﬁcant feature descriptors were employed to generate a feature vector for disease stage classiﬁcation. In
this study, all of feature values obtained by signiﬁcant descriptors were used as coeﬃcients of the feature vector.
The patched images were classiﬁed by using support vector machine (SVM) and Random Forests. In the SVM case,
one-leave-out cross-validation method was used for evaluation. In this study, these classiﬁcation was used R which is
software for statistical analysis.
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Table 3. Kolmogorov-Smirnov (K-S) test result of object-level features.
Type Features p-value
—– # of Nuclei < 0.01
Area
Elliptical Major Axis Length < 0.01
Minor Axis Length,
Eccentricity
Orientation
Elliptical Deviation
Extent
Aspect Ratio
Convex Hull Convex Area < 0.01
Convex Deﬁciency
Solidity
Bounding Box Extent < 0.01
Aspect Ratio
Boundary Perimeter < 0.01
Radii
Perimeter Curvature
Other Shape Equivalent Diameter < 0.01
Sphericity
Compactness
Inertia Shape
Table 4. Kolmogorov-Smirnov (K-S) test result of spatial-arrangement features.
Type Features p-value
Voronoi Tessellation # of Nodes < 0.01
# of Edges
Edge Length
Cyclomatic #
# of k-Walks
Degree
Spectral Radius
Randic Index
Voronoi Area
Voronoi Area Disorder
Perimeter
Roundness Factor
Roundness Factor Homogeneity
Delaunay Triangulation # of Nodes < 0.01
# of Edges
Edge Length
Cyclomatic #
# of Triangles
# of k-Walks
Degree
Spectral Radius
Randic Index
Minimum Spanning Tree # of Nodes < 0.01
# of Edges
Edge Length
Degree
Spectral Radius
Randic Index
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Table 5. Classiﬁcation results of SVM.
Type Vector Accuracy%
Object-level features # of Nuclei, Area 99.87
Major Axis Length, Minor Axis Length 98.46
Perimeter, Radii 98.76
Convex Area, Solidity 97.26
Equivalent Diameter, Sphericity 99.03
Voronoi Tessellation Voronoi Area, Voronoi Perimeter 82.48
Randic Index, # of Edges 80.72
# of Nodes, Cyclomatic # 82.88
# of 3 Walks, Roundness Factor 81.11
Voronoi Area Disorder, Roundness Factor Homogeneity 80.62
Delaunay Triangulation # of 3 Walks, # of 5 Walks 81.92
# of Triangles, Average Edges Length 82.66
Cyclomatic #, Randic Index 81.21
Minimum Spanning Tree Randic Index, Average Edge Length 83.05
# of Nodes, Degree 82.47
3. Experimental result and discussion
Tables 3 and 4 show the summarized Kolmogorov-Smirnov (K-S) test results on Object-Level features and Spatial-
Arrangement features, respectively. From the results, p-values of all features in Object-Level features and Spatial-
Arrangement features were eﬀective for evaluation of disease progression of Glioma. Because p-values of these
features were less than 0.01.
Table 5 shows the results of disease stage classiﬁcation using SVM. The results of SVM using Object-Level Fea-
tures show that 98.6% of Glioma images were classiﬁed correctly. And, the results of SVM using the features of VT,
DT and MST show 81.6%, 81.9% and 82.8%, respectively. Especially, in the case of Object-Level Features, these
combination were consisted from same type features. Actually, in the previous research have used only 1 .svs format
image in each category, the result of accuracy of SVM using Object-Level features was 98.7%. This accuracy was
not diﬀerence from the accuracy in this paper. However, the result of SVM using VT, DT and MST features were
99.3%, 98.8% and 99.3%. These accuracy ware vary diﬀerence from the accuracies in thi paper. From these result, we
thought that Object-Level features is better than Spatial-Arrangement features to classify the progression of Glioma
image in the TCGA Data.
Figures 5 show the graphs of Mean Decrease Gini in the case of each feature using Random Forests. As a result,
in the case of Object-Level features, classiﬁcation accuracy is 99.8% and we used mtry = 4. The value of mtry is
the parameter of Random Forest in the ”R” package. And mtry is the number of variables (
√
n: n is number of
features). On the other hand, in the case of VT which is Spatial-Arrangement features, classiﬁcation accuracy is
84.38% and we used mtry = 4. Similarly, in the case of DT and MST, classiﬁcation accuracy is 87.06% and 86.75%,
and mtry = 3, and = 2, respectively. These values of mtry were obtained by tuning step. Mean Decrease Gini is
importance for classiﬁcation of LGG and GBM, and these graphs indicate the importance of each features in disease
classiﬁcation. Therefore, the features which have high Mean Decrease Gini value are signiﬁcant features for disease
stage classiﬁcation in this study.
4. Conclusions
This paper discussed nucleus segmentation method, feature descriptors and disease stage classiﬁcation for Glioma
histopathology images. In this paper, we discussed nucleus segmentation method for LGG and GBM images of TCGA
Data. And, the feature descriptors deﬁned in the literature were applied to Glioma images, and statistical signiﬁcance
of them were discussed too. We also tried to distinguish LGG from GBM images by using the signiﬁcant descriptors,
based on support vector machines, and Random Forests based classiﬁers. After the experiments, more than 98.6% of
images were classiﬁed correctly using SVM which was consist of Object-Level features, and 82.1% of images were
classiﬁed correctly using SVM which was consist of Spatial-Arrangement features. In addition, more than 99.8% of
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(a) Object-Level (b) Voronoi Tessellation
(c) Delaunay Triangulation (d) MST
Fig. 5. Importance of various features in random forests based classiﬁer.
images were classiﬁed correctly using Random Forests in the case of Object-Level features, and more than 86.1% of
images were classiﬁed correctly using RF in the case of Spatial-Arrangement features. From these result, we thought
that the Object-Level features is better than Spatial-Arrangement features to classify the progression of Glioma image
in TCGA Data.
We are currently improving the overall image analysis pipeline with fuzzy entropy thresholding10, and active
contour for improving the accuracy of nuclei segmentation12. We will further investigate to discover disease subtypes
using feature matrices and conﬁrm relationship of the disease stage and gene expression available within the TCGA
data. We hope our automatic image analysis method will be of help in medical decision analysis in general, and brain
tumors in particular.
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